UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients

The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.

The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.

pharma & biotech
FDA Clears Genetic Modification in Pigs for Biomedicine and Food
FDA Clears Genetic Modification in Pigs for Biomedicine and Food
Catherine Offord | Dec 15, 2020
The decision, which concerns the removal of a sugar molecule on the surface of cells in a line of domestic pigs, marks the first time an approval has been granted for both purposes simultaneously.
Rocket Pharma
Rocket Pharma
The Scientist Staff | Dec 1, 2020
Take a peek inside one Israeli company’s push to send pharmaceutical research into space.
Pharma Looks to Outer Space to Boost Drug R&D
Pharma Looks to Outer Space to Boost Drug R&D
Katarina Zimmer | Dec 1, 2020
There are benefits of studying certain biological processes under microgravity, but whether those advantages outweigh the costs of getting experiments off Earth remains to be seen.
Science Is My Copilot
Science Is My Copilot
Bob Grant | Dec 1, 2020
As the world around us seems increasingly volatile, protecting and respecting the integrity of research and evidence becomes more important than ever.
Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
Max Kozlov | Oct 30, 2020
A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.
NYU Langone to Drop Sackler Name from Biomedical Institute
NYU Langone to Drop Sackler Name from Biomedical Institute
Max Kozlov | Oct 26, 2020
The decision comes after Purdue Pharma, founded by the Sackler family, announced it would plead guilty to federal criminal charges for its role in the opioid epidemic.
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Anthony King | Sep 8, 2020
Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?
Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
Catherine Offord | Sep 3, 2020
A meta-analysis of seven randomized controlled trials concludes that dexamethasone and other corticosteroids reduce 28-day mortality in seriously ill patients.
Last Chance to Enter Our Annual Top 10 Innovations Contest
Last Chance to Enter Our Annual Top 10 Innovations Contest
The Scientist Staff | Aug 18, 2020
The deadline is this Friday to submit your new product and have a chance at being selected for a coveted spot in The Scientist’s 2020 competition.